ShareValue scores for 603439.SHG: Valuation 49, Quality 42, Growth 31, Health 42.

603439.SHG
SSE

Guizhou Sanli Pharmaceutical Co Ltd

CN¥11.19(+0.90%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
49
Fair Value
Price vs Value
Quality
42
Moderate
Business Strength
Growth
31
Weak
Revenue & Earnings
Health
42
Moderate
Financial Stability
Momentum
32
Bearish
Price Trend

Company Details

About

Guizhou Sanli Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the plantation, research, development, production, and sale of pharmaceutical products in China. The company offers respiratory system, tonic, gynecological, and orthopedic medications, as well as cardiovascular and cerebrovascular drugs, and other medicines. It also provides products in various dosage forms, including sprays, granules, capsules, pills, tablets, medicated wines, and ointments. The company was founded in 1995 and is based in Anshun, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026